Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 3/20 | 0.35 |
| ▸ | RAB9A | P51151 | 3/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.35 |
| ▸ | NOTUM | Q6P988 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.35 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.35 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.35 |
| ▸ | TYR | P14679 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3817728 | 0.87 | CYP2C9 (0.38) | LMNAPTGS1TRPA1CACNA1CNPC1 | |
| SCHEMBL3818485 | 0.85 | KIF11 (0.39) | LMNAPTGS1TRPA1CACNA1CNPC1 | |
| SCHEMBL6915325 | 0.80 | LMNA (0.44) | LMNAPTGS1TRPA1CACNA1CNPC1 | |
| SCHEMBL5461557 | 0.80 | ACHE (0.42) | LMNANPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL3816568 | 0.79 | PTPN5 (0.37) | NPC1RAB9ANPSR1NOTUMTP53 | |
| SCHEMBL3821691 | 0.78 | RAB9A (0.37) | LMNANPC1RAB9ANPSR1NOTUM | |
| SCHEMBL28026885 | 0.77 | IDO1 (0.39) | LMNANPC1RAB9ANPSR1NOTUM | |
| SCHEMBL3819329 | 0.73 | RXRA (0.42) | PTGS2PTPN5CYP2C9 | |
| SCHEMBL7914615 | 0.73 | LMNA (0.41) | LMNANPC1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL840282 | 0.72 | METAP2 (0.40) | LMNAPTGS1KIF11PTGS2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10381579-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-08-13 | — | — | US | claimed |
| US-20150249225-A1 | STABILITY OLED MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-09-03 | — | — | US | claimed |
| US-9051344-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2015-06-09 | — | — | US | claimed |
| EP-1878053-B1 | STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY | UNIVERSAL DISPLAY CORP (US) | 2009-08-26 | — | — | EP | claimed |
| US-11404650-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-08-02 | — | — | US | disclosed |
| US-10381579-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-08-13 | — | — | US | disclosed |
| US-20150249225-A1 | STABILITY OLED MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-09-03 | — | — | US | disclosed |
| US-9051344-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2015-06-09 | — | — | US | disclosed |
| US-7902374-B2 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2011-03-08 | — | — | US | disclosed |
| EP-1878053-B1 | STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY | UNIVERSAL DISPLAY CORP (US) | 2009-08-26 | — | — | EP | disclosed |
| WO-2008054584-A1 | IMPROVED STABILITY OLED MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2008-05-08 | — | — | WO | disclosed |
| EP-1878053-A1 | STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY | Universal Display Corporation (US) | 2008-01-16 | — | — | EP | disclosed |
| US-20070088167-A1 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION | 2007-04-19 | — | — | US | disclosed |
| WO-2006121811-A1 | STABILITY OLED MATERIALS AND DEVICES WITH IMPROVED STABILITY | UNIVERSAL DISPLAY CORPORATION (US) | 2006-11-16 | — | — | WO | disclosed |
| US-20060251923-A1 | Stability OLED materials and devices | UNIVERSAL DISPLAY CORPORATION | 2006-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11404650-B2 | Stability OLED materials and devices | OCIAD2, OCIAD1, OSBP2 | LMNA 3178/4885PTGS1 4638/4885TRPA1 226/4885 |
| US-10381579-B2 | Stability OLED materials and devices | OCIAD2, OCIAD1, OSBP2 | LMNA 3210/4885PTGS1 4634/4885TRPA1 225/4885 |
| US-20150249225-A1 | STABILITY OLED MATERIALS AND DEVICES | OCIAD2, OCIAD1, OSBP2 | LMNA 3210/4885PTGS1 4634/4885TRPA1 225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.